CancerX shared a post on LinkedIn:
“We are delighted to welcome our new CancerX Accelerator Champions for 2026: AstraZeneca, Novartis, Rush University Medical Center, Atlantic Health, and Amazon Web Services (AWS) – joining 16 existing champions who have remained deeply engaged and energized heading into this next cohort. Together, these leading cancer centers, health systems, life sciences companies, payers, and investors are actively breaking down silos across the oncology ecosystem to create a truly collaborative space to co-build, pilot, and scale breakthrough digital innovations.
These champions don’t just advise – they select, steward, and open real acceleration pathways for the startups in our cohort.
Learn more about our incredible champions who really make the acceleration happen!
Applications are now open for the CancerX Accelerator and close on October 28, 2025.
More posts about Cancer X on OncoDaily.
